Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-4.116M
Cash
5.028M
Avg Qtr Burn
-2.153M
Short % of Float
3.70%
Insider Ownership
0.09%
Institutional Own.
2.51%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ADAIR (proprietary abuse-deterrent formulation of immediate-release) Details Attention deficit hyperactivity disorder | Phase 3 Update | |
GRI-0621 Details Idiopathic pulmonary fibrosis, Lung disease | Phase 2a Data readout | |
GRI-0803 Details Autoimmune disease, Systemic lupus erythematosus | IND Submission |